Piper Sandler Reiterates Overweight Rating on DexCom (DXCM)

August 3, 2026 10:07 AM

Piper Sandler analyst Matt O'Brien reiterated an Overweight rating and $95.00 price target on DexCom (NASDAQ: DXCM).The analyst commented: "Dexcom's ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found